David Tran

6.1k citations

39 papers · 1.4k indexed · h-index 20

Impact in

Genetics top 2%
- Glioma Diagnosis and Treatment
Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Genetics 25
- Glioma Diagnosis and Treatment 24
Structural Biology 1

Co-authors: Gregory D. Longmore Krishna Luitel Kun Zhang Michael Kim Hung D. Tran Albert H. Kim Hirak Biswas Jiayi Huang
Journals: Journal of Clinical Oncology (6 papers)Neuro-Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Neuro-Oncology (3 papers)Seminars in Oncology (2 papers)
Partner nations: United States Australia Canada

In The Last Decade

David Tran

38 papers receiving 1.4k citations

Peers

Countries citing papers authored by David Tran

Since Specialization

Citations

This map shows the geographic impact of David Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tran more than expected).

Fields of papers citing papers by David Tran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tran. The network helps show where David Tran may publish in the future.

Co-authors

The 25 scholars most cited alongside David Tran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Tran Line = papers co-authored together David Tran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma Neuro-Oncology ·William G. Breen, Jesse G. Dixon, S. Keith Anderson, Jann N. Sarkaria, Paul D. Brown, Elizabeth Yan, Sani H. Kizilbash, Evanthia Galanis, Daniel M. Anderson, David Tran, Miroslaw Mazurczak, Derek R. Johnson, Francois J. Geoffroy, Clinton Leinweber, Nadia N. Laack	2025	0
2	Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study Med ·Dongjiang Chen, Son B Le, Ashley Ghiaseddin, Harshit Manektalia, Ming Li, Adam O’Dell, Maryam Rahman, David Tran	2025	2
3	Histologic Findings at the Time of Repeat Resection Predicts Survival in Patients with Glioblastoma World Neurosurgery ·Kaitlyn Melnick, Patricia Miller, Ethan Carmichael, Yu Wang, David Tran, Jesse Kresak, Ashley Ghiaseddin, Maryam Rahman	2022	2
4	Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces MDM Policy & Practice ·Reka Pataky, Jaclyn Beca, David Tran, Wei Fang Dai, Erind Dvorani, Wanrudee Isaranuwatchai, Stuart Peacock, Riaz Alvi, Winson Y. Cheung, Craig C. Earle, Scott Gavura, Kelvin Chan	2021	9
5	A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872 Cancer ·Evanthia Galanis, S. Keith Anderson, Erin Twohy, Xiomara W. Carrero, Jesse G. Dixon, David Tran, Suriya Jeyapalan, Daniel M. Anderson, Timothy J. Kaufmann, Ryan W. Feathers, Caterina Giannini, Jan C. Buckner, Panos Z. Anastasiadis, David Schiff	2019	54
6	Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma Journal of Neuro-Oncology ·Jiayi Huang, Jian Campian, Amit D. Gujar, Christina Tsien, George Ansstas, David Tran, T.A. DeWees, A. Craig Lockhart, Albert H. Kim	2018	45
7	Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival. Journal of Clinical Oncology ·David M. Peereboom, Burt Nabors, Priya Kumthekar, Michael Badruddoja, Karen Fink, Frank S. Lieberman, Surasak Phuphanich, Erin Dunbar, Tobias Walbert, David Schiff, David Tran, Lynn S. Ashby, Nicholas Butowski, Fábio M. Iwamoto, Ross Lindsay, J. Bullington, Michael Schulder, Jonathan H. Sherman, Trishna Goswami, David A. Reardon	2018	12
8	Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy Radiotherapy and Oncology ·Simon Tang, James Otton, Lois Holloway, Geoff P. Delaney, Gary Liney, Armia George, Michael Jameson, David Tran, Vikneswary Batumalai, Liza Thomas, Eng‐Siew Koh	2018	27
9	Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series Case Reports in Neurology ·George Ansstas, David Tran	2016	19
10	Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors Disease Markers ·Andrei G. Vlassenko, Jonathan McConathy, Lars E. Couture, Yi Su, Parinaz Massoumzadeh, Hayden Leeds, Michael R. Chicoine, David Tran, Jiayi Huang, Sonika Dahiya, Daniel S. Marcus, Sarah Jost Fouke, Keith M. Rich, Marcus E. Raichle, Tammie L.S. Benzinger	2015	23
11	Impact of 1p/19q Codeletion and Histology on Outcomes of Anaplastic Gliomas Treated With Radiation Therapy and Temozolomide International Journal of Radiation OncologyBiologyPhysics ·Christina K. Speirs, Joseph R. Simpson, Clifford G. Robinson, T.A. DeWees, David Tran, Gerry Linette, Michael R. Chicoine, Ralph G. Dacey, Keith M. Rich, Joshua L. Dowling, Eric C. Leuthardt, Gregory J. Zipfel, Albert H. Kim, Jiayi Huang	2015	24
12	Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma International Journal of Radiation OncologyBiologyPhysics ·Jiayi Huang, T.A. DeWees, Shahed N. Badiyan, Christina K. Speirs, D. Mullen, S. Fergus, David Tran, Gerry Linette, Jian Campian, Michael R. Chicoine, Albert H. Kim, Gavin P. Dunn, Joseph R. Simpson, Clifford G. Robinson	2015	82
13	A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells Cell Reports ·Diane D. Mao, Amit D. Gujar, Tatenda Mahlokozera, Ishita Chen, Yanchun Pan, Jingqin Luo, Taylor M. Brost, E. A. Thompson, Alice Turski, Eric C. Leuthardt, Gavin P. Dunn, Michael R. Chicoine, Keith M. Rich, Joshua L. Dowling, Gregory J. Zipfel, Ralph G. Dacey, Samuel Achilefu, David Tran, Hiroko Yano, Albert H. Kim	2015	88
14	Transient SNAIL1 Expression Is Necessary for Metastatic Competence in Breast Cancer Cancer Research ·Hung D. Tran, Krishna Luitel, Michael Kim, Kun Zhang, Gregory D. Longmore, David Tran	2014	184
15	Radiation Therapy Dose Escalation for Glioblastoma Multiforme in the Era of Temozolomide International Journal of Radiation OncologyBiologyPhysics ·Shahed N. Badiyan, Stephanie Markovina, Joseph R. Simpson, Clifford G. Robinson, T.A. DeWees, David Tran, Gerry Linette, Rohan Jalalizadeh, Ralph G. Dacey, Keith M. Rich, Michael R. Chicoine, Joshua L. Dowling, Eric C. Leuthardt, Gregory J. Zipfel, Albert H. Kim, Jiayi Huang	2014	47
16	Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) Seminars in Oncology ·Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Yvonne Kew, Robert Cavaliere, John L. Villano, Daniela A. Bota, Jeremy Rudnick, Ashley Sumrall, Jay‐Jiguang Zhu, Nicholas Butowski	2014	119
17	Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas Neuro-Oncology ·Andrew Lin, Jingxia Liu, J.G. Evans, Eric C. Leuthardt, Keith M. Rich, Ralph G. Dacey, Joshua L. Dowling, Albert H. Kim, Gregory J. Zipfel, Robert L. Grubb, Jiayi Huang, Clifford G. Robinson, Joseph R. Simpson, Gerald P. Linette, Michael R. Chicoine, David Tran	2013	16
18	Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial–Mesenchymal Transition Predicts for Human Breast Cancer Recurrence Molecular Cancer Research ·David Tran, Callie A.S. Corsa, Hirak Biswas, Rebecca Aft, Gregory D. Longmore	2011	136
19	Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABAA receptors Molecular and Cellular Neuroscience ·Yuan Xu, Jun Yao, David E. Norris, David Tran, Richard J. Bram, Gong Chen, Bernhard Lüscher	2008	37
20	CAML Is a p56Lck-Interacting Protein that Is Required for Thymocyte Development Immunity ·David Tran, Contessa E. Edgar, Karin L. Heckman, Shari L. Sutor, Catherine J. Huntoon, Jan van Deursen, David L. McKean, Richard J. Bram	2005	31

About David Tran

David Tran is a scholar working on Genetics, Structural Biology, Biotechnology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Cancer Research and Treatments (5 papers), Signaling Pathways in Disease (4 papers), Meningioma and schwannoma management (4 papers), Cancer Genomics and Diagnostics (3 papers) and Vascular Malformations Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (568 citations), Oncology (485 citations), Cancer Research (255 citations), Cell Biology (148 citations) and Structural Biology (12 citations). David Tran has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Gregory D. Longmore, Krishna Luitel, Kun Zhang, Michael Kim, Hung D. Tran, Albert H. Kim, Hirak Biswas, Jiayi Huang, Rebecca Aft and Callie A.S. Corsa. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Neuro-Oncology and Seminars in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact